Zeria Pharmaceutical Co Ltd
TSE:4559
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Zeria Pharmaceutical Co Ltd
Zeria Pharmaceutical Co Ltd
Other Current Liabilities
Zeria Pharmaceutical Co Ltd
Other Current Liabilities Peer Comparison
4502
4568
4578
4519
4503
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
Other Current Liabilities
¥11.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Other Current Liabilities
¥1.4T
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
12%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Other Current Liabilities
¥165.9B
|
CAGR 3-Years
85%
|
CAGR 5-Years
39%
|
CAGR 10-Years
12%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Other Current Liabilities
¥366.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
5%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Other Current Liabilities
¥150.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Other Current Liabilities
¥628.3B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
See Also
What is Zeria Pharmaceutical Co Ltd's Other Current Liabilities?
Other Current Liabilities
11.4B
JPY
Based on the financial report for Mar 31, 2024, Zeria Pharmaceutical Co Ltd's Other Current Liabilities amounts to 11.4B JPY.
What is Zeria Pharmaceutical Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
4%
Over the last year, the Other Current Liabilities growth was 35%. The average annual Other Current Liabilities growth rates for Zeria Pharmaceutical Co Ltd have been 19% over the past three years , 8% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
